Study on ketoacidosis from diabetes drug before surgery
Part of Hormones & metabolism clinical trials.
This study looks at whether taking a common diabetes medicine (SGLT2 inhibitor) before surgery can lead to a serious condition called ketoacidosis. Researchers want to understand how often this happens and how it affects recovery after staying in the hospital overnight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been taking an SGLT2 inhibitor medication (like empagliflozin, dapagliflozin, or canagliflozin) regularly in the last 3 months, even if you stopped before surgery.
- You are scheduled for a surgery that will require at least one overnight stay in the hospital.
- You are willing and able to give your consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how stopping a common diabetes drug (SGLT2 inhibitor) affects the body's risk of a serious condition called ketoacidosis. It may help understand who is most at risk and how to prevent it.
This trial tests whether patients with heart failure having heart surgery should stop taking their SGLT-2 inhibitor (like empagliflozin or dapagliflozin) or keep taking it, to see which is safer and better.
This study tests a dual continuous ketone and glucose monitor to help prevent diabetic ketoacidosis (DKA) in people with type 1 diabetes who are starting SGLT2 inhibitor treatment. SGLT2 inhibitors are a newer type of diabetes medicine, but they can increase the risk of DKA. The device may make using these medicines safer.
This study tests a device that monitors ketone levels to help reduce the risk of diabetic ketoacidosis (DKA) for people with type 1 diabetes who are taking a class of medications called SGLT-2 inhibitors. The goal is to see if regular ketone tracking can make these medications safer.
This trial tests how combining a ketone supplement with certain diabetes medicines affects blood sugar and ketone levels. It may help adults with type 2 diabetes who are not on insulin or certain other drugs.
This trial tests how stopping a type 2 diabetes medication called an SGLT2 inhibitor affects the liver's production of sugar and ketones. It may help understand better ways to manage diabetes.
Hear when a new SGLT2 Inhibitor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.